Inflammatory Mediators and Clinical Outcome in Patients with Advanced Heart Failure Receiving Cardiac Resynchronization Therapy

American Journal of Cardiology

Volumn 117, Issue 4, 2016, Pages 617-625

  Belperio, John ^a   Horwich, Tamara ^a   Abraham, William T ^b   Fonarow, Gregg C ^a   Gorcsan, John ^c   Bersohn, Malcolm M ^a,d   Singh, Jagmeet P ^e   Sonel, Ali ^c,f   Lee, Li Yin ^g   Halilovic, Jasmina ^g   Kadish, Alan ^h   Shalaby, Alaa A ^c,h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g ST JUDE MEDICAL   (United States)

^h NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; BIOLOGICAL MARKER; CYTOKINE; SIGNAL PEPTIDE;

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MEDIATOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD; CLINICAL TRIAL; FOLLOW UP; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; INFLAMMATION; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; TIME FACTOR; TREATMENT OUTCOME;

AGED; BIOMARKERS; CARDIAC RESYNCHRONIZATION THERAPY; CYTOKINES; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 84959036645     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.11.049     Document Type: Article

References (26)

1. J.J. Bax, T. Abraham, S.S. Barold, O.A. Breithardt, J.W. Fung, S. Garrigue, J. Gorcsan 3rd, D.L. Hayes, D.A. Kass, J. Knuuti, C. Leclercq, C. Linde, D.B. Mark, M.J. Monaghan, P. Nihoyannopoulos, M.J. Schalij, C. Stellbrink, and C.M. Yu Cardiac resynchronization therapy: Part 1-issues before device implantation J Am Coll Cardiol 46 2005 2153 2167
2. A. El-Saed, A. Voigt, and A. Shalaby Usefulness of brain natriuretic peptide level at implant in predicting mortality in patients with advanced but stable heart failure receiving cardiac resynchronization therapy Clin Cardiol 32 2009 E33 E38
3. N. Lellouche, C. De Diego, D.A. Cesario, M. Vaseghi, B.N. Horowitz, A. Mahajan, I. Wiener, N.G. Boyle, G.C. Fonarow, and K. Shivkumar Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy Am J Cardiol 99 2007 242 246
4. A.A. Shalaby, W.T. Abraham, G.C. Fonarow, M.M. Bersohn, J. Gorcsan 3rd, L.Y. Lee, J. Halilovic, S. Saba, A. Maisel, J.P. Singh, A. Sonel, and A. Kadish Association of BNP and troponin levels with outcome among cardiac resynchronization therapy recipients Pacing Clin Electrophysiol 38 2015 581 590
5. K. Toli, K.I. Paraskevas, M.V. Poulakou, G. Agrogiannis, N. Kavantzas, V. Xanthopoulos, D.G. Iliopoulos, I. Mantas, A. Papachristodoulou, E. Patsouris, D.P. Mikhailidis, and D.N. Perrea Association between plasma levels and immunolocalization of cytokines in heart valve lesions: a possible target for treatment? Expert Opin Ther Targets 12 2008 1209 1215
6. M. Afanasyeva, Y. Wang, Z. Kaya, S. Park, M.J. Zilliox, B.H. Schofield, S.L. Hill, and N.R. Rose Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype Am J Pathol 159 2001 193 203
7. C. Nogae, N. Makino, T. Hata, I. Nogae, S. Takahashi, K. Suzuki, N. Taniguchi, and T. Yanaga Interleukin 1 alpha-induced expression of manganous superoxide dismutase reduces myocardial reperfusion injury in the rat J Mol Cell Cardiol 27 1995 2091 2099
8. S. Szardien, H.M. Nef, S. Voss, C. Troidl, C. Liebetrau, J. Hoffmann, M. Rauch, K. Mayer, K. Kimmich, A. Rolf, J. Rixe, K. Troidl, B. Kojonazarov, R.T. Schermuly, S. Kostin, A. Elsässer, C.W. Hamm, and H. Möllmann Regression of cardiac hypertrophy by granulocyte colony-stimulating factor-stimulated interleukin-1beta synthesis Eur Heart J 33 5 2012 595 605
9. G. Szebenyi, and J.F. Fallon Fibroblast growth factors as multifunctional signaling factors Int Rev Cytol 185 1999 45 106
10. M. Hetzel, M. Bachem, D. Anders, G. Trischler, and M. Faehling Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts Lung 183 2005 225 237
11. M.A. Jantz, and V.B. Antony Pleural fibrosis Clin Chest Med 27 2006 181 191
12. S.E. Mutsaers, I. Kalomenidis, N.A. Wilson, and Y.C. Lee Growth factors in pleural fibrosis Curr Opin Pulm Med 12 2006 251 258
13. F. Strutz, and E.G. Neilson New insights into mechanisms of fibrosis in immune renal injury Springer Semin Immunopathol 24 2003 459 476
14. L. Xiao, Y. Du, Y. Shen, Y. He, H. Zhao, and Z. Li TGF-beta 1 induced fibroblast proliferation is mediated by the FGF-2/ERK pathway Front Biosci (Landmark Ed) 17 2012 2667 2674
15. J.T. Meij, F. Sheikh, S.K. Jimenez, P.W. Nickerson, E. Kardami, and P.A. Cattini Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent Am J Physiol Heart Circ Physiol 282 2002 H547 555
16. J. Chen, J.K. Chen, K. Nagai, D. Plieth, M. Tan, T.C. Lee, D.W. Threadgill, E.G. Neilson, and R.C. Harris EGFR signaling promotes TGF beta-dependent renal fibrosis J Am Soc Nephrol 23 2012 215 224
17. M. Ghazizadeh, M. Tosa, H. Shimizu, H. Hyakusoku, and O. Kawanami Functional implications of the IL-6 signaling pathway in keloid pathogenesis J Invest Dermatol 127 2007 98 105
18. M. Pang, L. Ma, R. Gong, E. Tolbert, H. Mao, M. Ponnusamy, Y.E. Chin, H. Yan, L.D. Dworkin, and S. Zhuang A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy Kidney Int 78 2010 257 268
19. R. Samarakoon, A.D. Dobberfuhl, C. Cooley, J.M. Overstreet, S. Patel, R. Goldschmeding, K.K. Meldrum, and P.J. Higgins Induction of renal fibrotic genes by TGF-beta1 requires EGFR activation, p53 and reactive oxygen species Cell Signal 25 2013 2198 2209
20. A. Tzouvelekis, P. Ntolios, A. Karameris, G. Vilaras, P. Boglou, A. Koulelidis, K. Archontogeorgis, K. Kaltsas, G. Zacharis, E. Sarikloglou, P. Steiropoulos, D. Mikroulis, A. Koutsopoulos, M. Froudarakis, and D. Bouros Increased expression of epidermal growth factor receptor (EGF-R) in patients with different forms of lung fibrosis Biomed Res Int 2013 2013 654354
21. W. Zhang, W. Wang, H. Yu, Y. Zhang, Y. Dai, C. Ning, L. Tao, H. Sun, R.E. Kellems, M.R. Blackburn, and Y. Xia Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage Hypertension 59 2012 136 144
22. C.M. Birner, C. Ulucan, S. Fredersdorf, M. Rihm, H. Löwel, J. Stritzke, H. Schunkert, C. Hengstenberg, S. Holmer, G. Riegger, and A. Luchner Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: superiority of BNP Cytokine 40 2007 89 97
23. L. Tamariz, and J.M. Hare Inflammatory cytokines in heart failure: roles in aetiology and utility as biomarkers Eur Heart J 31 2010 768 770
24. P. Matzinger Friendly and dangerous signals: is the tissue in control? Nat Immunol 8 2007 11 13
25. Y. Morita, M. Yamamura, M. Kawashima, T. Aita, S. Harada, H. Okamoto, H. Inoue, and H. Makino Differential in vitro effects of IL-4, IL-10, and IL-13 on proinflammatory cytokine production and fibroblast proliferation in rheumatoid synovium Rheumatol Int 20 2001 49 54
26. S.M. Opal, and V.A. DePalo Anti-inflammatory cytokines Chest 117 2000 1162 1172